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Abstract
In an ideal world, researchers and decision-makers would be involved from the outset in co-producing evidence,
with local health needs assessments informing the research agenda and research evidence informing the actions
taken to improve health. The first step in improving the health of individuals and populations is therefore gaining
a better understanding of what the main health problems are, and of these, which are the most urgent priorities
by using both quantitative data to develop a health portrait and qualitative data to better understand why the local
population thinks that addressing certain health challenges should be prioritized in their context. Understanding the
causes of these health problems often involves analytical research, such as case-control and cohort studies, or qualitative
studies to better understand how more complex exposures lead to specific health problems (e.g. by interviewing local
teenagers discovering that watching teachers smoke in the school yard, peer pressure, and media influence smoking
initiation among youth). Such research helps to develop a logic model to better map out the proximal and distal causes
of poor health and to determine potential pathways for intervening and impacting health outcomes. Rarely is there
a single ‘cure’ or stand-alone intervention, but rather, a continuum of strategies are needed from diagnosis and
treatment of patients already affected, to disease prevention, health promotion and addressing the upstream social
determinants of health. Research for developing and testing more upstream interventions must often go beyond
randomized controlled trials, which are expensive, less amenable to more complex interventions, and can be associated
with certain ethical challenges. Indeed, a much neglected area of the research cycle is implementation and evaluation
research, which often involves quasi-experimental research study designs as well as qualitative research, to better
understand how to derive the greatest benefit from existing interventions and ways of maximizing health improvements
in specific local contexts. There is therefore a need to alter current incentive structures within the research enterprise
to place greater emphasis on implementation and evaluation research conducted in collaboration with knowledge
users who are in a position to use the findings in practice to improve health.
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“Even if the cure for HIV was one glass of clean water, we
wouldn’t be able to cure the world.” – Technical Officer
at the World Health Organization, Geneva, Switzerland
Background
To help people make better-informed decisions about
improving health and reducing health inequities, an im-
portant question is, what evidence is needed in support-
ing these decisions [1]? There is a large body of
biomedical research evidence that looks at single dis-
eases and considers randomized controlled trials (RCTs)
to be the gold standard in determining whether a given
medicine or device will benefit a specific patient group
as compared to no treatment (i.e. placebo) or the
current standard of care. However, in the field of public
health, where the aim is to improve the health of entire
populations, a more complex arsenal of research study
designs are needed that better address the complexity
and contextual nuances involved, as well as ensuring
that research evidence is co-produced with knowledge
users who are able to implement changes that in
practice will lead to improved health outcomes. Even
for diseases where there is a known prevention or
cure, people are still dying from these conditions be-
cause we lack knowledge on how to make these treat-
ments work in practice in a variety of contexts. The
purpose of this article series is therefore to describe
how to produce evidence for improving the health of
populations and how to ensure that this evidence is
then used to make better informed decisions for
health. The first article in this series focuses on the
different kinds of study designs and approaches that
can be used, beyond the traditional focus on RCTs,
for producing evidence that can help to improve
population health and reduce health inequities.
Review
It may appear self-evident, but the type of research stud-
ies needed to build up the evidence base on how to
improve population health and reduce inequities
depends on the research questions being asked. For
instance, if you want to know the most pressing health
priorities in a given population, then you cannot use an
RCT to answer this research question. Rather, you might
use a cross-sectional survey, a longitudinal panel or a
qualitative interview study with key informants. There-
fore, different types of research studies are needed to
answer different research questions at different stages in
the research cycle (Fig. 1). Increasingly, research for
health is becoming more multidisciplinary and intersec-
toral in nature to reflect the growing appreciation that
improving health requires intervention at multiple levels,
including action on the social determinants on health
[2]. The research cycle presented here is therefore an it-
erative process that involves co-production of knowledge
between researchers and decision-makers and provides
supporting evidence for the series of actions that are re-
quired to improve the health of individuals and
populations.
PRIORITIES
1. What is the nature
and extent of the health
problem and is it a
priority?
CAUSES
2. What are the proximal
and distal causes of the
health problem?
INTERVENTIONS








5. How well does the
intervention work in the
real world context? Synthesis,
dissemination
and utilization
Fig. 1 The research cycle: priorities, causes, interventions, implementation, evaluation [1]
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Defining health priorities
The first step in improving the health of individuals and
populations is better understanding what the main
health problems are, and of these, which are the most
urgent priorities and why. According to the PRECEDE-
PROCEED model [3], quantitative data can be used to
create a health portrait of the frequency and severity of
context-specific health problems (i.e. the ‘objective
health needs’), but qualitative data is also needed to
explore the perceptions of whether these health prob-
lems are considered by the local population to be a
priority and why (i.e. the ‘subjective health needs’). For
instance, the US National Health and Nutrition Examin-
ation Survey [4], and similar surveys in other countries,
ask about disease prevalence and may also include direct
assessments of the health condition (e.g. identifying
diabetes by doing blood sugar tests). However, in
addition to knowing about how many people have the
health problem and how many new cases develop
each year, it is also important to know the severity of
the health problem. This, in turn, has important
implications for the health system, especially in rela-
tion to non-communicable diseases, including mental
health conditions, addictions, gender-based violence,
child maltreatment and other chronic problems that
can cause prolonged suffering, greatly impacting qual-
ity of life and increasing the need for care over long
periods of time, even if there may not be a significant
impact on mortality. To better understand in what
ways health problems actually affect people, it is
necessary to ask people directly. Therefore, qualitative
research can be used to tease out how a health prob-
lem impacts people’s lives and what kind of support
would be most helpful.
When prioritizing which health problems should be
the focus of further research (i.e. moving to step 2 in the
research cycle) it is not sufficient to simply make a rank-
ing of the health conditions which result in the largest
number of deaths, disability-adjusted life years or which
cost the most money. According to Green and Kreuter’s
“Precede-Procede” model for health planning, in addition
to the ‘objective needs assessment’ based on surveillance
data and descriptive surveys, there should also be a ‘sub-
jective needs assessment’ that considers the viewpoint of
the local population [5]. People want to be involved [6],
and their voices should be heard to ensure a fair process
[7] since these decisions will ultimately affect them. Quali-
tative research is more participatory and inclusive by using
purposive sampling to obtain a wide range of perspectives,
including those in the minority who may be more margin-
alized. Thus, it is an important way of involving various
populations or target groups in providing their own views
and empowering them in determining their own health
priorities and identifying their preferred solutions [8].
Understanding the causes of the health problem
Once the major health priorities are identified, the next
step is to better understand the causes of the health
problems as a basis for identifying effective interven-
tions. Epidemiological studies, such as case-control and
cohort studies, can demonstrate whether there is an
association between an exposure (such as smoking) and
an outcome (such as lung cancer) [9, 10].
However, the causes of health problems are often
complex and involve a number of proximal risk factors
as well as upstream determinants of health. For instance,
smoking (i.e. a risk factor) causes lung cancer, but what
causes people to start smoking in the first place, and to
continue smoking for decades? Indeed, there is a whole
literature on the various factors such as peer pressure,
marketing and social norms which influence young
people to start smoking [11]. Even non-smokers are at
risk of disease and therefore need to be protected from
environmental tobacco smoke [12]. A ‘logic model’ can
explain the complex relationship between the various
causal factors and the health problem as a starting point
for developing interventions to target these causes. For
instance, the Task Force on Community Preventive Ser-
vices developed a logic model for interventions to pre-
vent the initiation of smoking, to promote smoking
cessation and to reduce exposure to environmental
tobacco smoke as a means of reducing disease incidence
and mortality (Fig. 2) [13].
The next step in the research cycle is determining what
works to improve health. This involves developing new in-
terventions or identifying existing interventions that act
on the causes of poor health, and then conducting further
research to assess which of these interventions actually
makes a difference in improving health outcomes.
Developing interventions to improve health outcomes
In developing and testing interventions, we want to
know whether the intervention works, how well it
works, whether there are any unwanted negative conse-
quences, whether the benefits of the intervention out-
weigh the harms, and how much this will cost per
incremental improvement in health. While RCTs have
long been the gold standard for determining the efficacy
of an intervention, these studies can nonetheless have
certain methodological challenges that can affect the in-
ternal and external validity, and hence the usefulness of
the results [14]. This led to the development of the
CONSORT reporting standards to at least be able to
better judge these shortcomings and determine the util-
ity of the data for decision-making [15]. However, even
beyond issues relating to validity of results, RCTs can be
extremely expensive, less amenable to studying more
complex interventions at the health system or popula-
tion level, and are also subject to important ethical
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considerations [16, 17], which are beyond the scope of
this article. Therefore, alternative study designs are im-
portant and increasingly being used, and include pre-
post studies where the population serves as its own con-
trol group and stepped-wedge designs with sequential
roll-out of interventions over time [18], both of which
offer certain advantages, but like all research studies,
also have their limitations [19].
Implementing and evaluating research in a real-world
context
The final steps in the research cycle are traditionally the
implementation and evaluation of the intervention in
‘real world’ settings rather than controlled research set-
tings. Nevertheless, in population health research, where
interventions are often complex and where it can be dif-
ficult to find ‘controlled settings’, the boundaries between
the development of interventions, and their implementa-
tion and evaluation, can be blurred. Ultimately, what we
really want to know is whether an intervention has im-
proved the health of the population and has reduced
health inequities.
Commonly used ways of assessing whether there has
been a positive change in population health are quasi-
experimental studies such as pre-post studies, natural
experiments and stepped-wedge designs. If an interven-
tion has been shown to produce a positive impact on
health, policymakers would also want to know how
much the actual implementation of the intervention will
cost, and what the incremental cost per additional health
benefit produced would be. Economic evaluations can
attempt to provide this information, though often rely
upon modelling based on a variety of assumptions which
may or may not reflect the reality in a given context.
Moreover, demonstrating that an intervention is inex-
pensive and able to produce a health benefit in a con-
trolled research setting is very different from ensuring
that the health benefit can be realized within a given
budget when the intervention is implemented on a
larger scale in a ‘real world’ setting.
The tail end of the research cycle which deals with im-
plementation and evaluation is a grey zone where re-
search blends into practice. In research, the purpose is
to generate new knowledge and to develop and test hy-
potheses. This entails using the various research study
designs described above and it also requires ethical ap-
proval to protect research participants (regardless of the
study design chosen, since all studies pose certain ethical
challenges that should not be overlooked) [20]. In con-
trast, the purpose of implementation and evaluation is
to improve the effectiveness and efficiency of programs
and policies by modifying, adapting and adjusting these
in accordance with lessons learnt from actually using
them (and studying how they work) in practice.
According to WHO, most research to date has focused
on the development of new interventions rather than
optimizing the delivery of existing interventions. There
is therefore a call for more research that “focuses on
studying how research outcomes can be translated into
practice” [21]. Of course, the type of research that suc-
ceeds in being funded reflects the priorities established
by funding agencies, which tend to be overly concerned
with developing new technologies and securing intellec-
tual property agreements rather than optimizing delivery
and utilization in local contexts. According to Leroy et
al. [22], “ninety-seven percent of grants were for
Fig. 2 Logic model to reduce tobacco use and exposure to environmental tobacco smoke. Adapted from [13]
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developing new technologies, which could reduce child
mortality by 22%. This reduction is one third of what
could be achieved if existing technologies were fully uti-
lized”. Indeed, many evidence-based innovations fail to
generate the expected health impact when transferred to
communities in the global South, largely because their
implementation is untested, unsuitable or incomplete
[23]. If the goal of research is improving population
health and saving lives, then funding agencies need to
rethink whether they are investing in the right places.
In an attempt to maximize the health impact of research
by optimizing delivery and utilization of existing technolo-
gies, WHO developed an implementation research plat-
form to better understand the challenges of generalizing
research findings in the real world and contextualizing
interventions for implementation in specific settings [24].
Similarly, evaluation research is intended to assist
decision-makers in making better informed choices about
whether or not to continue, modify or discontinue a cer-
tain policy or program. Not only is this important for per-
formance management by demonstrating accountability,
transparency and the judicious use of public funds [25],
but ultimately, evaluation research is important to ensure
that the interventions implemented are indeed improving
the health and well-being of individuals and populations.
Thus, greater investment and infrastructure is required to
ensure that such research takes place, since far too many
programs and policies are put into place without much
attention to the underlying evidence base, and are then
left in place for years or even decades, with little or no
continuous quality improvement to ensure that they are
producing the outcomes initially intended.
Conclusions
There are many different types of research studies that
can help to answer a wide variety of research questions.
However, in practice, there are certain types of studies
that generally prevail, whereas other types are few and
far between. For instance, until recently, there was rela-
tively little work in the area of implementation and
evaluation research as most research was focused on
earlier stages of the research cycle. Indeed, researchers
would develop research protocols, apply for funding,
conduct their research studies to measure disease or
understand causes or test simple disease-specific inter-
ventions, prepare manuscripts for publication in high-
impact peer-reviewed journals often concluding that
“more research is needed”, and then start the process all
over again – essentially bypassing the implementation
and evaluation stages. Therefore, organizations which
support research must acknowledge the importance of
implementation and evaluation research and provide the
necessary resources to develop research capacity and
support submitted proposals to strengthen the know-
ledge base in these fields of research.
It is also increasingly being recognized that research
evidence will have very little effect if it does not reach
the local knowledge users who are in a position to apply
this information to motivate change. Ideally, according
to Parry et al. [26], these knowledge users and decision-
makers should be engaged in the research process from
the very outset, to help inform the key knowledge gaps
that need to be addressed and to then ‘translate’ the
evidence into policy and practice. This increased em-
phasis on ‘integrated knowledge translation’, also known
as co-production of research evidence, certainly requires
more time and effort to build up the required interdis-
ciplinary and intersectoral partnerships, but it also
increases the chances that the research findings will be
applied and used in practice and will yield tangible
results in the long run. Integrated knowledge translation
implies that researchers must play an important role in
helping knowledge users frame health priorities in a way
which can be addressed by the different kinds of re-
search study designs available, often requiring mixed
methods approaches to tease out complex issues.
Even if researchers are progressively being encouraged
to think about how the research findings can be applied
in practice and can now apply for a growing number of
knowledge dissemination grants, there nonetheless re-
main perverse incentive systems in the way that research
is funded which lead to some types of research being
prioritized over others; not because it is more important
nor because it will lead to more significant health gains,
but due to the way in which the research enterprise is
structured. In this regard, researchers, especially in aca-
demic settings, tend to focus on ‘publications’, ‘professor-
ships’ and ‘patents’, rather than ‘policy’, ‘practice’ and
‘people’ [27]. Indeed, the evidence base is hugely biased
towards basic science and clinical research (e.g. the
effect on blood pressure from using anti-hypertensive
medications) rather than population research (e.g. the
impact of grassroots community development and social
norm modification on the incidence of family violence
and child maltreatment). Pratt and Loff [28] further
argue that research legislation and policies used in high-
income countries have increasingly led these countries
to invest in health research aimed at boosting national
economic competitiveness rather than reducing health
inequities and that the ‘gadget health’ approach “diverts
funding away from research that is needed to implement
existing interventions and to strengthen health systems,
i.e. health policy and systems research”.
To ensure that we do not lose sight of the true goals
of health research, it is important to look at the big pic-
ture and not be blinded by academic or commercial
interests, such as the ‘publish or perish’ imperative or
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the hype surrounding new technologies [29]. There are
no ‘magic bullets’ or easy cures for the world’s health
problems, which are largely a reflection of underlying
economic, social, cultural and political problems. Fur-
ther, there is little point in producing all of this research
evidence if it is not used to make better-informed deci-
sions and policies to improve health. Incentive systems,
such as greater availability of funding mechanisms and
research awards tailored to this area, and which
recognize the importance of applying research in prac-
tice, are therefore required. Beyond the amount of publi-
cations produced, what if researchers were instead
judged based on their efforts to inform the development,
implementation and evaluation of policies and programs
that prevent human suffering, save lives and reduce
inequities? Perhaps then we really would see the benefits
of research in practice.
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